HANNAH CUMMINGS: Open Payments
NPI 1194219394 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 106 payments from 28 companies in 2025. Trend: 2023 $1,593 · 2024 $2,155 · 2025 $1,901
Food & beverage: $1,801Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 15 | $329 |
| Novo Nordisk Inc | 13 | $231 |
| ABBVIE INC. | 17 | $202 |
| PFIZER INC. | 10 | $167 |
| Tris Pharma Inc | 7 | $137 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Lilly USA, LLC | 5 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Eisai Inc. | 2 | $62 |
Products named: Veozah, Wegovy, Dyanavel XR, VRAYLAR, Leqembi, PREVNAR 20, XIFAXAN, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
